Human Serum and Plasma Protein Depletion – Novel High-Capacity Affinity Column for the Removal of the “Top 14” Abundant Proteins

Importance of the Topic

Serum and plasma proteomes serve as key biofluids for biomarker discovery and clinical monitoring. Their high complexity and wide concentration range of proteins pose analytical challenges: abundant proteins obscure low-abundance species, hindering detection by mass spectrometry and gel electrophoresis. Selective removal of major proteins enhances dynamic range and reveals potential disease markers.

Objectives and Study Overview

This study presents the design and evaluation of a novel high-capacity affinity column (Human 14) for specific depletion of the top 14 most abundant proteins from human serum and plasma. The goals included assessing depletion efficiency, reproducibility over multiple runs, and impact on downstream proteomic analyses.

Methodology and Instrumentation

Sample Preparation and Depletion Protocol:

• Dilution of serum/plasma 1:4 in neutral Buffer A (pH 7.4), particulate removal by spin filtration.
• Automated HPLC-based immunoaffinity depletion using Buffer A for loading/washing and low-pH urea Buffer B for elution.
• Collection of flow-through (low-abundance fraction) and bound (high-abundance proteins) fractions.

Analytical Techniques:

• ELISA assays to quantify removal of each targeted protein.
• BCA assay for total protein concentration.
• SDS-PAGE with Coomassie staining to visualize depletion and flow-through profiles.
• LC/MS/MS analysis of bound fractions after in-gel digestion, using reversed-phase nano-LC on an HPLC Chip coupled to an XCT Ultra trap and Spectrum Mill database search.

Instrumentation Used

• Agilent 1100 HPLC system with binary pump, thermostatted autosampler, diode array detector, column compartment, and fraction collector.
• Predesigned Multiple Affinity Removal System Human 14 column (4.6×100 mm) containing antibody and affibody ligands.
• Invitrogen pre-cast Tris-Glycine SDS-PAGE gels and Bio-Rad blocker solution.
• Protein In-gel Tryptic Digestion Kit and HPLC-Chip/XCT Ultra trap for LC/MS/MS.

Main Results and Discussion

The Human 14 column consistently removed approximately 94% of total protein mass across 200 sequential runs. ELISA quantification showed >99% depletion for albumin, IgG, IgA, transferrin, and other high-abundance targets, with lowest removal greater than 97% for transthyretin and fibrinogen. SDS-PAGE profiles demonstrated clear absence of major protein bands in flow-through fractions and unmasking of low-abundance proteins. LC/MS/MS of bound fractions identified minimal nonspecific binding, confirming high specificity. The column maintained reproducible chromatographic performance and showed no carry-over between injections.

Benefits and Practical Applications

• Enhanced detection of low-abundance proteins in downstream 2D gel electrophoresis and LC-MS/MS workflows.
• Improved sample loading capacity and simplified data interpretation by reducing sample complexity.
• High robustness and automated compatibility for routine clinical and research laboratories.

Future Trends and Opportunities

Integration with high-throughput robotic platforms and expansion to additional target panels may further accelerate biomarker discovery. Combining immunodepletion with orthogonal fractionation methods and advanced mass spectrometers will deepen proteome coverage. Clinical applications in diagnostics and monitoring will benefit from streamlined sample preparation and standardized workflows.

Conclusion

The Agilent Human 14 affinity column delivers reliable, high-capacity removal of 14 abundant serum and plasma proteins, enabling enriched analysis of low-abundance biomarkers with excellent reproducibility over hundreds of runs.

Reference

1. C. Szafranski et al., Enhancing analytical access to low-abundant proteins in the human plasma proteome, PharmaGenomics, 2004, pp. 40–46.
2. K. Bjorhall, T. Miliotis, P. Davidsson, Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples, Proteomics, 2005, 5, 307–317.
3. B.A. Chromy et al., Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins, J. Proteome Res., 2004, 3, 1120–1127.